Oric Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
240 E. Grand Ave., 2 Nd Floor, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/12/2024, 04:22 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Nov 12, 2024
SC 13G Report Nov 8, 2024
SC 13G Report Oct 22, 2024
SC 13G/A Report Mar 11, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report Feb 9, 2024
SC 13G/A Report Feb 7, 2024
SC 13G/A Report Feb 6, 2024
SC 13G Report SC 13G Feb 1, 2024
SC 13G Report SC 13G Jan 30, 2024
SC 13G Report Jan 29, 2024
SC 13G Report SC 13G Jan 25, 2024
SC 13G Report SC 13G Jul 7, 2023
SC 13G Report SC 13G Jun 12, 2023
SC 13G/A Report Feb 13, 2023
SC 13G/A Report Feb 10, 2023
SC 13G/A Report Feb 9, 2023
SC 13G/A Report Feb 6, 2023
SC 13G Report Jan 20, 2023
SC 13G Report SC 13G ORIC PHARMACEUTICALS Dec 29, 2022
SC 13G Report Jul 8, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 11, 2022
SC 13G/A Report Feb 9, 2022
SC 13G/A Report Feb 3, 2022
SC 13G Report Feb 2, 2022
SC 13G/A Report Feb 16, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report Feb 8, 2021
SC 13G Report Feb 2, 2021
SC 13G/A Report SC 13G/A Nov 5, 2020
SC 13G Report May 11, 2020
SC 13G Report May 1, 2020
SC 13G Report SCHEDULE 13G Apr 29, 2020